Because research is key to unlocking the future of cancer care, Mary Bird Perkins TGMC Cancer Center is proud to be the only hospital in the region offering 32 in-house oncology clinical trials. These trials enhance standard cancer treatments and can result in improved patient outcomes and survival rates by seeking the safest and most effective treatments for specific cancer types. Every patient at the Cancer Center is evaluated for participation, enabling as many individuals as possible to be on the leading edge of cancer care close to home.
Those considering participation in a trial will receive a thorough explanation from their doctor with information needed to make an informed decision. Physicians offer many clinical trials at any given time, including brain, breast, colorectal, head and neck, kidney, lung, melanoma, pancreas and prostate studies.